This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,163.76, is for the delivery of Ketorolac 30 mg/ml vial, a pain management medication. The contract has a firm fixed price pricing type and a completion date of December 17, 2024. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/17/25, 9:54 AM